Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 11 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
MOS device for eliminating floating body effects and self-heating effects
Method of and apparatus for image denoising
Method and system for detecting data modification within computing device
UV exposure method for reducing residue in de-taping process
Automotive lighting system
Methods and apparatus to identify exposure to 3D media presentations
Adjusting dental prostheses based on soft tissue
  Randomly Featured Patents
Use of ribozymes in the detection of adventitious agents
Method and system for platform level data model for indications based event control and data transfer
Spout assembly adapted to be in fluid communication with a faucet
Animal ear holder apparatus and method of obtaining desired animal behavior
Electrical connector and method of manufacturing same
Sports watching method using mobile communication means of motion picture
Automated vending system for floral arrangements
Method for controlling heat of a metal hydride container
Method and system for automatically associating a manually entered postage amount to a class of service
Sole plate coating for a fabric pressing device